The National Medical Products Administration is not really responsible for regulating pharmaceutical ingredients produced and exported by chemical organizations. This regulatory absence, that has resulted in appreciable Global information protection unfavorable to China, continues to be recognized for a decade, but failure of Chinese regulatory bus